C&R Research Inc. Logo

C&R Research Inc.

A full-service CRO providing clinical research for pharma and medical device companies.

359090 | KO

Overview

Corporate Details

ISIN(s):
KR7359090008
LEI:
Country:
South Korea
Address:
서울특별시 강남구 역삼로 412 (대치동, 씨엔알빌딩), 강남구

Description

C&R Research Inc. is a full-service Contract Research Organization (CRO) providing comprehensive clinical research services for pharmaceutical, biotechnology, and medical device companies. The company's offerings span the entire product lifecycle, from early-phase development and clinical trial design to regulatory affairs, data management, statistical consulting, and trial management. C&R Research is actively transitioning into a 'Data CRO' by integrating artificial intelligence (AI), Real-World Data (RWD), and platform-based solutions to enhance the efficiency and quality of clinical trials. The organization supports global studies, including navigating regulatory submissions with international bodies such as the U.S. FDA, and has demonstrated expertise in complex therapeutic areas like oncology, advanced biologics, and innovative medical devices.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-02-12 00:00
주주총회집중일개최사유신고
Korean 4.8 KB
2025-02-12 00:00
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 12.0 KB
2024-12-23 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.5 KB
2024-12-13 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-14 00:00
분기보고서 (2024.09)
Korean 1.4 MB
2024-09-23 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 22.2 KB
2024-08-14 00:00
반기보고서 (2024.06)
Korean 1.5 MB
2024-07-02 00:00
기업설명회(IR)개최
Korean 6.7 KB
2024-05-14 00:00
분기보고서 (2024.03)
Korean 1.4 MB
2024-04-29 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 20.9 KB
2024-04-24 00:00
[기재정정]전환청구권행사 (제1회차)
Korean 12.4 KB
2024-04-24 00:00
[기재정정]전환청구권행사 (제1회차)
Korean 12.4 KB
2024-04-09 00:00
전환청구권행사 (제1회차)
Korean 9.3 KB
2024-03-27 00:00
정기주주총회결과
Korean 22.8 KB
2024-03-19 00:00
감사보고서제출
Korean 26.5 KB

Automate Your Workflow. Get a real-time feed of all C&R Research Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for C&R Research Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for C&R Research Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.